Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
Authors
Yajie Liu (ORCID: https://orcid.org/0000-0003-1215-7788)
Yonghong Hu (ORCID: https://orcid.org/0000-0002-8268-8763)
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
Yajie Liu, Yonghong Hu, Xinhua Jiang, Qiaoxuan Wang et al.
Citations
7 citations
Journal
BMJ
Topics
Head and Neck Cancer Studies
Field-Weighted Citation Impact (FWCI)
12.94
article
Four cycles of docetaxel plus cisplatin as neoadjuvant chemotherapy followed by concurrent chemoradiotherapy in stage N2-3 nasopharyngeal carcinoma: phase 3 multicentre randomised controlled trial
Sun Yat-sen University (CN), Ganzhou People's Hospital (CN), Key Laboratory of Guangdong Province (CN), Peking University Shenzhen Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), First Affiliated Hospital of Gannan Medical University (CN), Sun Yat-sen University Cancer Center (CN), Guangzhou Medical University Cancer Hospital (CN), Shenzhen Second People's Hospital (CN), State Key Laboratory of Oncology in South China, Guangzhou Medical University (CN)